Stock Events

Stock Events

Agios Pharmaceuticals (8AP.F) Q1 2026 Earnings

12FebConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-1.69

-1.58

-1.48

-1.37

Details

Expected EPS

-1.64607713832

Actual EPS

-1.5671244

Surprise EPS

0.08

Surprise Percent

+4.8%

Description

Agios Pharmaceuticals (8AP.F) has reported earnings of -1.5671244 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.